Shopping Cart

The shopping cart is empty

View courses and libraries and add them to the cart

{{item.title}} {{item.ceu}} hour {{item.ceu}} hours {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

{{item.title}} {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

Customers who Purchased
this Activity also Purchased

PREMIUM

{{recommendationsA.Title}}

Article
{{recommendationsA.Ceu}} hour | {{recommendationsA.Price | currency}} Article
{{recommendationsA.Ceu}} hours | {{recommendationsA.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsA.Type}} {{recommendationsA.Type}}

PREMIUM

{{recommendationsB.Title}}

Article
{{recommendationsB.Ceu}} hour | {{recommendationsB.Price | currency}} Article
{{recommendationsB.Ceu}} hours | {{recommendationsB.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsB.Type}} {{recommendationsB.Type}}

Total

{{totalCEUs}} hour{{totalCEUs}} hours

{{cart.total_amount | currency}}

@media (max-width: 991px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; } .site-header.fixed-top { position: relative; } .site-header .container-fluid { flex-flow: row wrap; } .nav-site-toggle { display: none; } .site-logo { position: static; top:auto; left:auto; transform: none; margin: 10px auto; order: 1; } .nav-site { width: 100%; position: static; overflow: visible; background-color: #ffffff; order: 3; } .nav-site-close { display: none; } .nav-site .nav-site-menu { width: 100%; height: auto; margin-left: 0; overflow: visible; } .nav-site .nav-item .dropdown-toggle::after{ display: none; } .nav-site .navbar-nav { margin: 0; padding: 0; position: relative; overflow: visible; overflow-y: visible; height: auto; } .nav-site .nav-breadcrumb { display: none; } .nav-site .nav-item .dropdown-toggle { background-color: #e1e1e1; text-transform: uppercase; } .nav-site .nav-item .dropdown-menu { position: static; margin: 0; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { font-weight: bold; background-color: #F2F4F6; } .nav-user { order: 2; margin: 0 10px 10px 10px; width: 100%; text-align: center; } .nav-user .user-menu { flex-flow: row wrap; } .nav-user .user-menu .user-menu-toggle { } .nav-user .user-menu .dropdown-menu { display: block; width: 100% !important; position: static; float: none; } .nav-user .user-menu .dropdown-menu::before, .nav-user .user-menu .dropdown-menu::after { display: none; } } @media (min-width: 992px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; margin-bottom: 500px; } .site-header.fixed-top { position: static; } .nav-site .nav-site-menu .navbar-nav .nav-item:hover > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item:focus-within > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.super { display: flex; flex-flow: row nowrap; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm1 { left: -376%; padding-right: 20px; width: 548px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:before { left: 80%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:after { left: 80.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 { left: 44%; padding-right: 20px; min-width: 6rem; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 .dropdown-item { min-width: 170px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:before { left: 5%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:after { left: 5.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { } .nav-user .user-menu .dropdown-menu { display: block; left: -20px; width: 210px !important; } .nav-user .user-menu .dropdown-menu .dropdown-item { min-width: 170px; } } .card-slider { overflow-x: auto; }

1. Which of the following syndromes is associated with the Janssen/Johnson & Johnson COVID-19 vaccine?

A. Heparin-induced thrombocytopenia (HIT) B. Thrombotic thrombocytopenic purpura (TTP) C. Idiopathic thrombocytopenic purpura (ITP) D. Thrombosis with thrombocytopenia syndrome (TTS) E. Unsure

2. According to nationwide survey reported recently in MMWR Morbidity and Mortality Weekly Reports from the CDC, people in which of the following age groups had the highest SARS-CoV-2 seroprevalence?

A. <18 years B. 18–49 years C. 50–64 years D. >65 years E. Unsure

3. Which of the following manufacturers was the first to received authorization for a COVID-19 vaccine to be administered in patients 5–11 years of age?

A. Pfizer/BioNTech B. Janssen/Johnson & Johnson C. Moderna D. Novavax E. Unsure

4. Rebound symptoms in people taking Paxlovid therapy for COVID-19?

A. Tend to occur shortly after beginning Paxlovid therapy B. Are likely due to antiviral resistance to nirmatrelvir C. Represent COVID-19 reinfection D. Tend to cease within about 3 days E. Unsure

5. According to the latest NIH COVID-19 treatment guidelines, which of the following strategies is recommended in a patient already taking amlodipine?

A. Avoid Paxlovid therapy. B. Temporarily hold amlodipine therapy. C. Continue amlodipine with monitoring. D. Adjust amlodipine dose by 50% with monitoring. E. Unsure

6. Which of the following agents is a monoclonal antibody that retains activity against the currently circulating omicron subvariants including BA.4 and BA.5?

A. Sotrovimab B. Bebtelovimab C. Paxlovid D. Molnupiravir E. Unsure

7. A patient with HIV would currently be recommended for booster doses if they had which of the following?

A. CD4 count of 500/mm3 B. Undetectable viral load C. Symptomatic HIV infection D. CD4 count of 500/mm3 with undetectable viral load E. Unsure

8. Baricitinib therapy should be withheld in patients with

A. White blood cell count of 15,000 X 106 per microliter B. Platelet count of 150,000/mm3 C. Absolute neutrophil count of 100 cells/microliter D. Absolute lymphocyte count of 400 cells/microliter E. Unsure

9. Which of the following statements correctly describes the current status or use of remdesivir in pediatric patients 28 days or older?

A. It is currently authorized by the FDA but not fully approved. B. It should be used only for treatment in the inpatient setting. C. Baseline labs including renal and hepatic function should be performed. D. Therapy must be given within 48 hours of documented COVID-19 infection. E. Unsure

10. A recently approved at-home COVID-19 test can additionally identify which of the following respiratory pathogens?

A. Respiratory syncytial virus B. Adenovirus C. Streptococcus pneumoniae D. Hemophilus influenzae E. Unsure

Evaluation Questions

11. To what extent did the program meet objective #1?

A. Excellent B. Very Good C. Good D. Fair E. Poor

12. To what extent did the program meet objective #2?

A. Excellent B. Very Good C. Good D. Fair E. Poor

13. Rate the effectiveness of how well the program related to your educational needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

14. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

A. Excellent B. Very Good C. Good D. Fair E. Poor

15. Rate the quality of the faculty:

A. Excellent B. Very Good C. Good D. Fair E. Poor

16. Rate the effectiveness and the overall usefulness of the material presented:

A. Excellent B. Very Good C. Good D. Fair E. Poor

17. Rate the appropriateness of the examination for this activity:

A. Excellent B. Very Good C. Good D. Fair E. Poor

18. Rate the effectiveness of how well the activity related to your practice needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

19. Rate the effectiveness of how well the activity will help you improve patient care:

A. Excellent B. Very Good C. Good D. Fair E. Poor

20. Will the information presented cause you to change your practice?

A. Yes B. No

21. Are you committed to making these changes?

A. Yes B. No

22. As a result of this activity, did you learn something new?

A. Yes B. No

23. What is your practice setting or area of practice?

A. Community Pharmacy/Independent B. Community Pharmacy/Chain C. Hospital/Health Systems D. Administrative/Pharmacy Director E. Critical Care Pharmacy F. Long-term Care G. Managed Care/PBM H. Oncology I. Specialty Pharmacy J. Industry/Manufacturing

24. How many years have you been in practice?

A. <5 B. 5 – 10 C. 11 – 20 D. >20

« Return to Activity